Promoting Maternal Mental Health and Wellbeing in Neonatal Intensive Care
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03942627|
Recruitment Status : Recruiting
First Posted : May 8, 2019
Last Update Posted : September 25, 2019
|Condition or disease||Intervention/treatment||Phase|
|Depressive Symptoms Anxiety Post-traumatic Stress Symptoms||Behavioral: Mindfulness Program Behavioral: Infant Health Education Program||Not Applicable|
An estimated 400,000-480,000 infants in the U.S. with serious medical conditions are cared for in neonatal intensive care units (NICUs) each year. Maternal stress exposure related to infants' NICU stays is an under-appreciated public health problem with negative implications for maternal and child health and wellbeing. Flexible, effective intervention strategies have potential to improve maternal mental health and parenting, promoting positive emotional and behavioral outcomes for both mothers and infants.
In the investigators' successful pilot research, the investigators developed an audio-delivered mindfulness program to help NICU mothers reduce rumination and worry, cultivate a state of calm awareness, and promote self care. In this small randomized pilot study, the investigators will randomly assign mothers with an infant in the neonatal intensive care unit (NICU) to receive either the mindfulness intervention or an active control program (audio-delivered education on infant care and development).
This study will evaluate feasibility of all key research aspects, including recruitment, randomization, intervention and control conditions, and assessments, in preparation for a future larger-scale study. This study will also assess preliminary intervention outcomes to identify potential program benefits.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||75 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||Promoting Maternal Mental Health and Wellbeing in Neonatal Intensive Care|
|Actual Study Start Date :||May 28, 2019|
|Estimated Primary Completion Date :||October 20, 2021|
|Estimated Study Completion Date :||October 20, 2021|
Experimental: Mindfulness Program
The intervention consists of an introductory video in which a mindfulness expert explains the program's approach and models practices to increase women's comfort with the material, four audio-recorded mindfulness practices for mothers' use when the baby is in the NICU, each available in 5- and 10-minute versions, and a brief video and four additional audio mindfulness practices (each available in briefer and longer versions) for use by mothers during and following the transition home with the baby.
Behavioral: Mindfulness Program
The intervention consists of two brief videos (one introducing the NICU portion of the program and one introducing the portion of the program addressing the transition home), as well as a series of mindfulness practices delivered via audio recordings to assist mothers in managing stress during the NICU stay and another series for the transition home.
Placebo Comparator: Infant Health Education Program
The intervention consists of an introductory video explaining the program's approach, four audio recordings providing education about infant health and development, each available in 5- and 10-minute versions, and a brief video and four additional educational recordings (each available in briefer and longer versions) for use by mothers during and following the transition home with the baby.
Behavioral: Infant Health Education Program
The active control condition consists of two brief videos (one introducing the NICU portion of the program and one introducing the portion of the program addressing the transition home), as well as a series of audio recordings providing information on infant health and development for mothers to use during the NICU stay and another series for the transition home.
- Depressive symptoms as assessed by the Patient Health Questionnaire (PHQ)-8 [ Time Frame: 2 weeks ]Self-reported depressive symptoms over the last 2 weeks. Each of the 8 items is scored 0 (not at all) to 3 (nearly every day), yielding a total between 0 and 24. Higher scores mean more depressive symptoms.
- Anxiety symptoms as assessed by the Generalized Anxiety Disorder - 7 (GAD-7) [ Time Frame: 2 weeks ]Self-reported anxiety symptoms over the last 2 weeks. Each of the 7 items is rated from 0 (not at all) to 3 (nearly every day), yielding a total between 0 and 21. Higher scores mean more anxiety.
- Trauma symptoms as assessed by the Stanford Acute Stress Reaction Questionnaire (SASRQ) [ Time Frame: 2 weeks ]31-item self-report measure of trauma symptoms. Items 1-30 are rated from 0 (not experienced) to 5 (very often experienced). Item 31 asks how many days symptoms were experienced since giving birth, ranging from no days to 5 or more days. Higher scores mean more frequent experience of trauma symptoms.
- Perceived stress as assessed by the Perceived Stress Scale - NICU (PSS-NICU) [ Time Frame: Up to 2 weeks ]Self-report measure of perceived stress related to the NICU containing 4 sub scales, each with items rated on a scale of 1 (not at all stressful) to 5 (very stressful). Higher scores mean more stress.
- Sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI) [ Time Frame: 4 weeks ]Self-reported measure assessing sleep quality
- Coping as assessed by the Brief Cope Scale [ Time Frame: Up to 2 weeks ]28-item self-reported measure of coping strategies. Items are rated on a scale ranging from 1 ("I usually don't do this at all") to 4 ("I usually do this a lot")
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03942627
|Contact: Tamar Mendelson, Ph.D.||(410)email@example.com|
|Contact: Erica Sibinga, M.D., Ph.D.||(410)firstname.lastname@example.org|
|Principal Investigator:||Erica Sibinga, M.D., Ph.D.||Johns Hopkins University|